S'abonner

Airborne dioxin exposure and breast cancer risk in a case-control study nested within the French E3 N prospective cohort - 05/07/18

Doi : 10.1016/j.respe.2018.05.034 
A. Danjou a, b, , T. Coudon a, b, D. Praud a, c, E. Lévêque d, E. Faure a, P. Salizzoni e
a Département cancer et environnement, centre Léon-Bérard, Lyon, France 
b Université Claude Bernard Lyon 1, université de Lyon, Villeurbanne, France 
c UMR Inserm 1052 CNRS 5286, équipe « Signalisation des hormones stéroïdes et cancer du sein », centre de recherche en cancérologie de Lyon, Lyon, France 
d Centre Inserm U1219 épidemiology and biostatistics, Institut de Santé publique, d’épidémiologie et de développement, université de Bordeaux, Bordeaux, France 
e Laboratory of Fluid Mechanics and Acoustics, École Centrale de Lyon, Ecully, France 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Introduction

Dioxins are a mixture of related chemicals emitted by industrial chlorinated combustion processes, including chemical manufacturing of pesticides, and activities from metallurgy, steel and municipal solid waste incineration. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) is the most potent dioxin congener and has been classified as a group 1 carcinogen by the International Agency for Research on Cancer, with sufficient evidence for all cancers combined. As a persistent endocrine disrupting chemical, TCDD is suspected to be involved in breast cancer (BC) etiology and may influence estrogen- and progesterone-mediated pathways. The long-term nature of airborne dioxin exposure may imply variations in exposure intensities over time and given their tumor promoting properties, the impact of dioxin exposures close to the time of diagnosis needs to be considered. We aimed to estimate BC risk associated with airborne dioxin exposure in a case-control study nested within the E3N cohort (“Étude Épidémiologique auprès de femmes de la Mutuelle Générale de l’Éducation Nationale”), improving the method for the assessment of low-dose airborne dioxin exposure and considering temporal dimensions of exposure in the risk estimates.

Methods

We designed a case-control study nested within the French E3N prospective cohort and restricted to the Rhône-Alpes region, France. Between 1990 and 2008, 429 invasive BC cases were diagnosed and matched to 716 controls on relevant factors. Assessment of airborne dioxin exposure was based on a detailed inventory of dioxin emitting sources and residential history of the study subjects. Exposure was evaluated at the individual address level with a geographic information system (GIS)-based exposure metric that included proximity to dioxin emitting sources and their technical characteristics, exposure duration and wind direction. We first estimated odds ratios (OR) and 95% confidence intervals (CI) for BC in relation to cumulative airborne dioxin exposure using conditional logistic regression models adjusting for main BC risk factors. We then estimated time-dependent effects of annual airborne dioxin exposure on overall BC risk according to time prior to diagnosis with a flexible time-dependent weight function.

Results

We observed no linear trend across quintiles of airborne dioxin exposure (P=0.81) and no increased risk of overall BC for higher dioxin exposure levels (OR for Q5 versus. Q1: 1.12, 95% CI: 0.69–1.82). We however observed a statistically significant OR for Q2 vs. Q1 (OR: 1.61, 95% CI: 1.04–2.49). For an increase of 0.1μg-TEQ/m2 in annual airborne dioxin exposure, risk estimates for overall BC according to time prior to diagnosis did not vary from 1.00 at each time point. No association was observed between airborne dioxin exposure and BC risk defined according to status of estrogen-receptor and progesterone-receptor.

Conclusions

No association was observed between airborne dioxin exposure and overall BC risk in our study population, as well as for hormone-receptor defined BC tumors. Our results suggested an increased risk in overall BC for Q2 vs Q1; this might be explained by the non-monotonic effect of dioxins, which has been suggested for other endocrine disruptor chemicals, meaning that the effect would be different depending on the dose and that stronger effects would be observed for lower levels of exposure. Confirmation of our findings is required in larger populations. Our study may provide a new tool for the assessment of long-term exposure with the GIS-based metric, as well as new ways of considering temporal dimensions for environmental exposures in disease risk assessment.

Le texte complet de cet article est disponible en PDF.

Plan


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 66 - N° S5

P. S245-S246 - juillet 2018 Retour au numéro
Article précédent Article précédent
  • Circulating levels of perfluoroalkylated compounds and breast cancer risk: Evidence from a nested case-control study
  • F.R. Mancini, G. Cano-Sancho, J. Gabaretti, P. Marchand, J.-P. Antignac, M. Kvaskoff
| Article suivant Article suivant
  • Impact of mean temperature on daily mortality in seven different bioclimatic regions in Tunisia, 1991–2011
  • H. Bellali, K. Talmoudi, W. Ettoumia, C. Harizi, N. Ben Alaya, M. Chahed

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.